Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian James

Showing results (241-250 of 244) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 244 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2017
Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical ActivityDidier Meulendijks, Wolfgang Jacob, Emile E Voest, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
HLA-B Alleles with Shared Peptide Binding Specificities Define Global Risk of Cotrimoxazole-induced SCARYueran Li, Andrew Gibson, Hajirah N Saeed, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 10, 2025
HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug ReactionsYueran Li, Andrew Gibson, Hajirah N Saeed, et al.
Acta Neuropathologica|September 16, 2024
Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosisMónica Zufiría, Oihane Pikatza-Menoio, Maddi Garciandia-Arcelus, et al.
Pageof 25

Showing results (241-250 of 244) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 244 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2017
Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical ActivityDidier Meulendijks, Wolfgang Jacob, Emile E Voest, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
HLA-B Alleles with Shared Peptide Binding Specificities Define Global Risk of Cotrimoxazole-induced SCARYueran Li, Andrew Gibson, Hajirah N Saeed, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 10, 2025
HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug ReactionsYueran Li, Andrew Gibson, Hajirah N Saeed, et al.
Acta Neuropathologica|September 16, 2024
Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosisMónica Zufiría, Oihane Pikatza-Menoio, Maddi Garciandia-Arcelus, et al.
Pageof 25